8-K
Current Report
Metagenomi Therapeutics, Inc. Filed Acc 0001193125-24-033697
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d770467d8k.htm…